We are live on ! Find out more
CCMU

Cheyne Capital Management (UK) Portfolio holdings

AUM $27.9M
1-Year Est. Return 36.14%
This Fund
S&P 500
This Quarter Est. Return
+18.51%
1 Year Est. Return
+36.14%
3 Year Est. Return
+35.61%
5 Year Est. Return
+211.68%
10 Year Est. Return
+661.99%
AUM
$415M
AUM Growth
+$34.5M
Cap. Flow
+$16.4M
Cap. Flow %
3.95%
Top 10 Hldgs %
74.24%
Holding
84
New
27
Increased
17
Reduced
6
Closed
19

Sector Composition

Rank Sector Weight
1 Healthcare 21.9%
2 Consumer Discretionary 16.02%
3 Technology 10.09%
4 Communication Services 6.82%
5 Industrials 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTV
1
DELISTED
DIRECTV COM STK (DE)
DTV
$39.3M 9.48%
462,243
+27,657
+6% +$2.39M
TRW
2
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
$38.5M 9.29%
367,475
+3,874
+1% +$402K
HSP
3
DELISTED
HOSPIRA INC
HSP
$37.9M 9.15%
+432,145
New +$33.9M
PCYC
4
DELISTED
PHARMACYCLICS INC
PCYC
$34.8M 8.4%
+136,078
New +$26.3M
DRC
5
DELISTED
DRESSER-RAND GROUP INC
DRC
$31.1M 7.5%
387,375
-72,832
-16% -$5.9M
RVBD
6
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
$30.4M 7.32%
+1,452,764
New +$30.2M
LTM
7
DELISTED
LIFE TIME FITNESS INC
LTM
$27.9M 6.73%
+393,174
New +$23.6M
SIAL
8
DELISTED
SIGMA - ALDRICH CORP
SIAL
$27.5M 6.64%
199,237
-25,049
-11% -$3.45M
TWC
9
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$26.5M 6.39%
176,791
-11,474
-6% -$1.71M
ICPT
10
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$13.9M 3.34%
49,137
+10,405
+27% +$2.25M
OREX
11
DELISTED
Orexigen Therapeutics, Inc.
OREX
$11.6M 2.8%
148,441
+42,575
+40% +$2.64M
CYBX
12
DELISTED
CYBERONICS INC
CYBX
$7.43M 1.79%
+114,488
New +$6.97M
INFI
13
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$6.75M 1.63%
483,262
+73,547
+18% +$1.12M
NKTR icon
14
Nektar Therapeutics
NKTR
$2.19B
$6.48M 1.56%
39,284
+16,056
+69% +$3.3M
ISEE
15
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$5.78M 1.39%
124,151
+32,664
+36% +$1.7M
MNTA
16
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$5.22M 1.26%
343,452
+78,944
+30% +$1.03M
ALLY icon
17
Ally Financial
ALLY
$14B
$4.26M 1.03%
203,171
-210,000
-51% -$4.42M
MDCO
18
DELISTED
Medicines Co
MDCO
$1.96M 0.47%
+70,000
New +$1.97M
NRF
19
DELISTED
NorthStar Realty Finance Corp.
NRF
$1.86M 0.45%
51,400
+13,862
+37% +$513K
UNP icon
20
Union Pacific
UNP
$176B
$1.62M 0.39%
15,000
+10,000
+200% +$1.17M
HON icon
21
Honeywell
HON
$71.7B
$1.56M 0.38%
16,693
+11,129
+200% +$1.02M
MLM icon
22
Martin Marietta Materials
MLM
$33.2B
$1.54M 0.37%
+11,000
New +$1.41M
APD icon
23
Air Products & Chemicals
APD
$66.1B
$1.51M 0.36%
10,810
+5,405
+100% +$748K
ALIM
24
DELISTED
Alimera Sciences
ALIM
$1.51M 0.36%
20,129
+15,057
+297% +$1.18M
CRTO icon
25
Criteo
CRTO
$1.11B
$1.4M 0.34%
35,300
+300
+0.9% +$12.5K

Similar funds

Cheyne Capital Management (UK)'s Q1 2015 Portfolio in Review

As of Q1 2015, Cheyne Capital Management (UK) held 84 positions worth $415M, up 9.1% from $380M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Cheyne Capital Management (UK) deployed $16.4M of net new capital in Q1 2015, opening 27 new positions and adding to 17 existing holdings. Its largest new stake was HOSPIRA INC: 432,145 shares worth $37.9M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was DRESSER-RAND GROUP INC, an estimated $5.9M trimmed.

  • Cheyne Capital Management (UK)'s largest Q1 2015 buy was HOSPIRA INC: 432,145 shares worth $37.9M.
  • Cheyne Capital Management (UK) added most to Nektar Therapeutics in Q1 2015, an estimated $3.3M increase.
  • Cheyne Capital Management (UK)'s biggest Q1 2015 reduction was DRESSER-RAND GROUP INC, cutting an estimated $5.9M.
  • Cheyne Capital Management (UK) fully exited CUBIST PHARMACEUTICALS INC in Q1 2015, selling an estimated $37.6M.
  • Cheyne Capital Management (UK)'s ten largest holdings make up 74% of its $415M portfolio in Q1 2015.
  • Cheyne Capital Management (UK) opened 27 new positions and closed 19 in Q1 2015.
  • Cheyne Capital Management (UK)'s portfolio value rose 9.1% quarter-over-quarter to $415M.

Based on Cheyne Capital Management (UK)'s 13F filing for Q1 2015, filed 11 May 2015.